Research Industries Corp. reports earnings of $620,835 or 10 cents per share for the third fiscal quarter ended March 31, up 63 percent over the same period last year.
Earnings for the nine-month period were $1.61 million or 27 cents per share, up 60 percent over the $1.01 million or 18 cents per share in the same period a year ago.Total revenues for the quarter, including real estate divestments, were $3.2 million, up from $2.3 million a year ago. The company said the increase in revenues was generated largely by health care products sales, which rose 36 percent to $2.8 million from $2.1 million a year earlier.
Sales of the firm's cardiovascular specialty catheters rose 79 percent in the quarter and 78 percent for the nine months. Proprietary pharmaceutical products sales increased 9 percent for the nine months.